Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Fuentes Mateos, R."'
Autor:
Kortekaas RK; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Geillinger-Kästle KE; Department of Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Fuentes-Mateos R; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schönleber A; Department of Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., van der Koog L; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elferink RAB; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Al-Alyan N; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Burgess JK; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Gosens R; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Oct 15; Vol. 38 (19), pp. e70077.
Autor:
Fuentes-Mateos R; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain.; Present address: Department of Molecular Pharmacology, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, Netherlands., García-Navas R; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain., Fernández-Infante C; Instituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC. Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., Hernández-Cano L; Instituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC. Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.; Present address: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands., Calzada-Nieto N; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain., Juan AO; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain., Guerrero C; Instituto de Biología Molecular y Celular del Cáncer (IMBCC), USAL-CSIC. Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., Santos E; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain. esantos@usal.es., Fernández-Medarde A; Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca) and CIBERONC, Campus Unamuno, University of Salamanca, 37007, Salamanca, Spain. afm@usal.es.
Publikováno v:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jun 17; Vol. 22 (1), pp. 332. Date of Electronic Publication: 2024 Jun 17.
Autor:
Kortekaas RK; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Geillinger-Kästle KE; Department of Immunology and Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Fuentes-Mateos R; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands., van Orsoy R; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Al-Alyan N; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Burgess JK; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Gosens R; Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jun 07; Vol. 15, pp. 1346491. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).
Autor:
Fuentes-Mateos R; Department of Molecular Pharmacology University of Groningen Groningen, the Netherlands., Gosens R; Department of Molecular Pharmacology University of Groningen Groningen, the Netherlands.
Publikováno v:
American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2024 Mar; Vol. 70 (3), pp. 153-154.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Villalba Cuesta P; Department of Medical Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain., Avedillo Ruidiaz M; Department of Medical Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain., Ruiz Hispán E; Department of Medical Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain., Fuentes Mateos R; Department of Medical Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain., Lamarca A; Department of Medical Oncology-OncoHealth Institute, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Nov 23; Vol. 15 (23). Date of Electronic Publication: 2023 Nov 23.
Autor:
Baltanás FC; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain. fcalvo@us.es.; Institute of Biomedicine of Seville (IBiS)/'Virgen del Rocío' University Hospital/CSIC/University of Seville and Department of Medical Physiology and Biophysics, University of Seville, Seville, Spain. fcalvo@us.es., García-Navas R; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Rodríguez-Ramos P; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Calzada N; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Cuesta C; Lab 5. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca, 37007, Salamanca, Spain., Borrajo J; Departament of Biomedical Sciences and Diagnostic, University of Salamanca, 37007, Salamanca, Spain., Fuentes-Mateos R; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Olarte-San Juan A; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Vidaña N; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain., Castellano E; Lab 5. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca, 37007, Salamanca, Spain., Santos E; Lab 1. Cancer Research Center, Institute of Cancer Molecular and Cellular Biology, CSIC-University of Salamanca and CIBERONC, 37007, Salamanca, Spain. esantos@usal.es.
Publikováno v:
Nature communications [Nat Commun] 2023 Sep 20; Vol. 14 (1), pp. 5856. Date of Electronic Publication: 2023 Sep 20.
Autor:
Earl, J., Barreto, E., Rodriguez, M., Villalon López, J., Fuentes Mateos, R., Garcia García de Paredes, A., Sanjuanbenito, A., Lobo, E., Ruz-Caracuel, I., Muñoz Beltran, M., Ramos, E., Blaquez, J., Carrato Mena, A.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S913-S913
Autor:
San-Román-Gil M; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Torres-Jiménez J; Medical Oncology Department, Clínico San Carlos University Hospital, 28040 Madrid, Spain., Pozas J; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Esteban-Villarrubia J; Medical Oncology Department, 12 de Octubre University Hospital, 28041 Madrid, Spain., Albarrán-Fernández V; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Álvarez-Ballesteros P; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Chamorro-Pérez J; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Rosero-Rodríguez D; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Orejana-Martín I; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Martínez-Delfrade Í; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Reguera-Puertas P; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Fuentes-Mateos R; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain., Ferreiro-Monteagudo R; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jan 30; Vol. 15 (3). Date of Electronic Publication: 2023 Jan 30.
Autor:
Fuentes-Mateos R; Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca/CSIC and CIBERONC, 37007 Salamanca, Spain., Santos E; Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca/CSIC and CIBERONC, 37007 Salamanca, Spain., Fernández-Medarde A; Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca/CSIC and CIBERONC, 37007 Salamanca, Spain.
Publikováno v:
Methods and protocols [Methods Protoc] 2023 Jan 24; Vol. 6 (1). Date of Electronic Publication: 2023 Jan 24.